Literature DB >> 14572164

Leukemia-lymphoma cell lines as model systems for hematopoietic research.

Hans G Drexler1, Roderick A F MacLeod.   

Abstract

Continuous human leukemia-lymphoma (LL) cell lines comprise a rich self-renewing resource of accessible and manipulable living cells which has illuminated the pathophysiology of hematopoietic tumors as well as basic cell biology. The major key advantages of continuous cell lines are the unlimited supply and worldwide availability of identical cell material and their cryopreservation. LL cell lines are characterized generally by monoclonal origin and differentiation arrest, sustained proliferation in vitro with preservation of most cellular features, and specific genetic alterations. The most practical classification of LL cell lines assigns them to one of the physiologically occurring cell lineages, based on their immunophenotype, genotype and functional features. Truly malignant cell lines may be distinguished from Epstein-Barr virus (EBV)-immortalized normal cells, using various operational and conceptual parameters. The characterization and publication of new LL cell lines provides important and informative core data which, by opening new avenues for investigation, have become ubiquitous powerful research tools that are available to every investigator by reference cell repositories. There is a need in the scientific community for clean and authenticated LL cell lines to which every scientist has access as offered by these institutionalized public cell line banks. A list of the most useful, robust and freely available reference cell lines is proposed in this review. Clearly, studies of LL cell lines have provided seminal insights into the biology of hematopoietic neoplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572164     DOI: 10.1080/07853890310012094

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  8 in total

1.  Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics.

Authors:  Ann-Catrin Andersson; Sara Strömberg; Helena Bäckvall; Caroline Kampf; Mathias Uhlen; Kenneth Wester; Fredrik Pontén
Journal:  J Histochem Cytochem       Date:  2006-09-06       Impact factor: 2.479

2.  The LL-100 panel: 100 cell lines for blood cancer studies.

Authors:  Hilmar Quentmeier; Claudia Pommerenke; Wilhelm G Dirks; Sonja Eberth; Max Koeppel; Roderick A F MacLeod; Stefan Nagel; Klaus Steube; Cord C Uphoff; Hans G Drexler
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

Review 3.  The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.

Authors:  Hans G Drexler; Hilmar Quentmeier
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

4.  Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases.

Authors:  P O Vorobyev; F E Babaeva; A V Panova; J Shakiba; S K Kravchenko; A V Soboleva; A V Lipatova
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

5.  Immune evasion by oncogenic proteins of acute myeloid leukemia.

Authors:  Shlomo Elias; Rachel Yamin; Lior Golomb; Pinchas Tsukerman; Noah Stanietsky-Kaynan; Dina Ben-Yehuda; Ofer Mandelboim
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

Review 6.  Role of the ubiquitin system and tumor viruses in AIDS-related cancer.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

7.  Differential Activity of Voltage- and Ca2+-Dependent Potassium Channels in Leukemic T Cell Lines: Jurkat Cells Represent an Exceptional Case.

Authors:  Salvador Valle-Reyes; Georgina Valencia-Cruz; Liliana Liñan-Rico; Igor Pottosin; Oxana Dobrovinskaya
Journal:  Front Physiol       Date:  2018-05-09       Impact factor: 4.566

8.  Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway.

Authors:  Lotte Eijkenboom; Callista Mulder; Bert van der Reijden; Norah van Mello; Julia van Leersum; Thessa Koorenhof-Scheele; Didi Braat; Catharina Beerendonk; Ronald Peek
Journal:  J Assist Reprod Genet       Date:  2021-03-16       Impact factor: 3.412

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.